MEK5 Promotes Lung Adenocarcinoma

Overview

Journal Eur Respir J

Specialty Pulmonary Medicine

Date 2018 Nov 17

PMID 30442718

Citations 7

Authors

Adrian Sanchez-Fdez

Maria Jesus Ortiz-Ruiz

Maria Florencia Re-Louhau

Isabel Ramos

Oscar Blanco-Munez

Dolores Ludena

Mar Abad

Manuel Sanchez-Martin

Atanasio Pandiella

Azucena Esparis-Ogando

Affiliations

Soon will be listed here.

Citing Articles

ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression.

Guillen-Perez Y, Ortiz-Ruiz M, Marquez J, Pandiella A, Esparis-Ogando A Int J Mol Sci. 2024; 25(6).

PMID: 38542254 PMC: 10970367. DOI: 10.3390/ijms25063273.

The significance of ERK5 catalytic-independent functions in disease pathways.

Le N Front Cell Dev Biol. 2023; 11:1235217.

PMID: 37601096 PMC: 10436230. DOI: 10.3389/fcell.2023.1235217.

Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications.

Sanchez-Fdez A, Matilla-Almazan S, Carmen S, Abad M, Arconada-Luque E, Jimenez-Suarez J Exp Mol Med. 2023; 55(6):1247-1257.

PMID: 37332046 PMC: 10317974. DOI: 10.1038/s12276-023-01008-x.

Clinical Significance and Regulation of ERK5 Expression and Function in Cancer.

Monti M, Celli J, Missale F, Cersosimo F, Russo M, Belloni E Cancers (Basel). 2022; 14(2).

PMID: 35053510 PMC: 8773716. DOI: 10.3390/cancers14020348.

Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer.

Sanchez-Fdez A, Re-Louhau M, Rodriguez-Nunez P, Ludena D, Matilla-Almazan S, Pandiella A NPJ Precis Oncol. 2021; 5(1):78.

PMID: 34404896 PMC: 8371118. DOI: 10.1038/s41698-021-00218-8.

References

ENGLISH J, Pearson G, Hockenberry T, Shivakumar L, White M, Cobb M . Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. J Biol Chem. 1999; 274(44):31588-92. DOI: 10.1074/jbc.274.44.31588. View

Nicol R, Frey N, Pearson G, Cobb M, Richardson J, Olson E . Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 2001; 20(11):2757-67. PMC: 125475. DOI: 10.1093/emboj/20.11.2757. View

Esparis-Ogando A, Diaz-Rodriguez E, Carlos Montero J, Yuste L, Crespo P, Pandiella A . Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol. 2001; 22(1):270-85. PMC: 134212. DOI: 10.1128/MCB.22.1.270-285.2002. View

Zhong C, Zhou Y, Douglas G, Witschi H, Pinkerton K . MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis. 2005; 26(12):2187-95. DOI: 10.1093/carcin/bgi189. View

Jiang J, Greulich H, Janne P, Sellers W, Meyerson M, Griffin J . Epidermal growth factor-independent transformation of Ba/F3 cells with cancer-derived epidermal growth factor receptor mutants induces gefitinib-sensitive cell cycle progression. Cancer Res. 2005; 65(19):8968-74. DOI: 10.1158/0008-5472.CAN-05-1829. View

Wang X, Tournier C . Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal. 2005; 18(6):753-60. DOI: 10.1016/j.cellsig.2005.11.003. View

Vargo-Gogola T, Rosen J . Modelling breast cancer: one size does not fit all. Nat Rev Cancer. 2007; 7(9):659-72. DOI: 10.1038/nrc2193. View

Yang Q, Lee J . Targeting the BMK1 MAP kinase pathway in cancer therapy. Clin Cancer Res. 2011; 17(11):3527-32. PMC: 3107913. DOI: 10.1158/1078-0432.CCR-10-2504. View

Reck M, Hermes A, Tan E, Felip E, Klughammer B, Baselga J . Tissue sampling in lung cancer: a review in light of the MERIT experience. Lung Cancer. 2011; 74(1):1-6. DOI: 10.1016/j.lungcan.2011.05.002. View

10.

Lochhead P, Gilley R, Cook S . ERK5 and its role in tumour development. Biochem Soc Trans. 2012; 40(1):251-6. DOI: 10.1042/BST20110663. View

11.

Bunn Jr P . Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch Pathol Lab Med. 2012; 136(12):1478-81. DOI: 10.5858/arpa.2012-0295-SA. View

12.

Gyorffy B, Surowiak P, Budczies J, Lanczky A . Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer. PLoS One. 2013; 8(12):e82241. PMC: 3867325. DOI: 10.1371/journal.pone.0082241. View

13.

Simoes A, Rodrigues C, Borralho P . The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target. Drug Discov Today. 2016; 21(10):1654-1663. DOI: 10.1016/j.drudis.2016.06.010. View

14.

Orive-Ramos A, Seoane S, Ocana A, Pandiella A, Carlos Montero J . Regulation of the prometastatic neuregulin-MMP13 axis by SRC family kinases: therapeutic implications. Mol Oncol. 2017; 11(12):1788-1805. PMC: 5709617. DOI: 10.1002/1878-0261.12145. View